VEGFA and neoplasm: Anti-VEGFR treatments have been shown to induce hypoxia in the tumor microenvironment (TME), inducing extracellular matrix (ECM) remodeling and overexpression of hyaluronic acid in colorectal liver metastasis mouse models, conferring resistance to anti-VEGF therapy (82).